According to our preliminary experiments, HCT116 and SW620 cells were treated with <50 μM DAC, and HT29 cells were treated with <100 μM DAC, at which cell viability was >80%, in order to detect the effects of DAC on OCT3 expression in the three CRC cell lines. This evidence concerns the gene SLC22A3 and colorectal carcinoma.